<strong>Indian</strong> J. Pharm. Pract. 1(2), Jan-Mar, 20096. Kapoor B, Raina RK, Kapoor S. Drug prescribingpattern in a teaching hospital. Ind J Pharmacol 1985;17 (1):168.7. Pradhan SC, Shewade DG, Shashindran CH, BapnaJS. Drug utilization studies. National Med J India1988; 1:185.8. Bimo, Chowdhary A, Das A, Diwan V, Kafle KK,Mabadeje B. In: How to investigate drug use in healthfacilities (selected drug use indicator) actionprogramme on essential drugs. WHO <strong>of</strong>ficialpublication 1995;68.9. Tiwari H, Kumar A, Kulkarni SK. Prescriptionmonitoring <strong>of</strong> antihypertensive drug utilisation at thePanjab University Health Centre in India. OriginalArticle. Singapore Med J 2004; 45(3): 117.10. Mancia G, Grassi G. Antihypertensive treatment:past, present and future. J Hypertens 1998; 16:S1-7.11. Prisant LM, Beall SP, Nicholads GE, Feldman EB,Carr AA, Feldman DS. Biochemical, endocrine, andmineral effects <strong>of</strong> indapamide in black women. J ClinPharmacol 1990; 30:121-126.12. Hansson L. The place <strong>of</strong> beta-blockers in thetreatment <strong>of</strong> hypertension . Clin Exp Hypertens 1993;15:1257-1262.13. Chalmers J. The place <strong>of</strong> combination therapy in thetreatment <strong>of</strong> hypertension. Clin Exp Hypertens 1993;15:1299-1313.14. Alkhaja KA, Sequeira RP, Damanhori AH, MathurVS. Antihypertensive drug-associated sexualdysfunction: a prescription analysis-based study.Pharmacoepidemiol Drug Safe 2003; 12:203-212.68
<strong>Indian</strong> J. Pharm. Pract. 1(2), Jan-Mar, 2009<strong>APTI</strong>INTRODUCTIONVaginitis is described medically as an irritation and/orinflammation <strong>of</strong> the vagina. It is a very common diseaseaffecting millions <strong>of</strong> women each year. The three mostcommon vaginal infections reported each year arebacterial vaginosis (30-40%), candidiasis due to yeastinfection (20-25%) and trichomoniasis caused byprotozoal infection (15-20%). Vaginal infections canproduce a variety <strong>of</strong> symptoms, such as abnormal orincreased discharge, itching, fishy odor, irritation,painful urination or vaginal bleeding(1,2,3).Though the infections are not serious in nature, they canbecome chronic and the eradication <strong>of</strong> such infections is<strong>of</strong>ten difficult. If left untreated, bacterial vaginosis mayresult in increased risk <strong>of</strong> pelvic inflammatory disease(PID), infertility, pre-term birth, premature rupture <strong>of</strong>membranes, low birth weight, intra-amniotic infections,endometritis, cervical intra-epithelial neoplasia (CIN),post-gynecological surgery infections and increased risk<strong>of</strong> sexually transmitted diseases (4,5).<strong>Indian</strong> <strong>Journal</strong> <strong>of</strong> <strong>Pharmacy</strong> <strong>Practice</strong>Received on 10/02/2009 Modified on 19/02/2009Accepted on 19/02/2009 © <strong>APTI</strong> All rights reserved<strong>ijopp</strong>Preliminary Clinical Study <strong>of</strong> a Polyherbal Formulation (Wh1) inthe Treatment <strong>of</strong> Vaginitis1 2 34Vishnu Bapat *, Leena Alfred , Shobha Rani R.H , Pushpa. T. Ksheerasagar ,5 6Geetha Hegde , Soumya. K. Lund ,1. Vaidya Visharad, # 375 First B Main, First Phase, Girinagar, Bangalore 560 0852,3,6. Department <strong>of</strong> <strong>Pharmacy</strong> <strong>Practice</strong>, Al-Ameen College <strong>of</strong> <strong>Pharmacy</strong>, Bangalore.4. Retired Pr<strong>of</strong>essor <strong>of</strong> Gynaecology, Bangalore Medical College, Bangalore.5. Shreyas Poly Clinic & Laboratory , Chamarajpet, Bangalore.*Address for correspondence: vrbapat@yahoo.co.inAbstractVaginitis is a very common disease affecting millions <strong>of</strong> women each year with multifactorial etiology. If leftuntreated it can lead to various complications. Current medical therapy may temporarily reduce infection but tendto disrupt the normal vaginal flora. Hence, herbal therapy is gaining popularity in women on account <strong>of</strong> its reducedside effects and restoration <strong>of</strong> the normal vaginal flora. With this in view, a preliminary clinical study was conductedusing a polyherbal formulation (WH I), containing herbs with antifungal, antibacterial, antiseptic and astringentproperties. In this prospective clinical study, 36 patients presented with the symptoms <strong>of</strong> vaginitis <strong>of</strong> varyingetiology were treated successfully with the polyherbal formulation (WH I) and was found to be safe and effective(83%). The results <strong>of</strong> this study were found to be significant, thus this study will be extended on a large patientpopulation in future.Key Words: Vaginitis, Polyherbal preparation (WH 1), Clinical Study, Female, bacterial vaginosis,candidiasis,richomoniasis, leucorrhoea.Vaginitis is identified by checking vaginal fluidappearance, vaginal pH and presence <strong>of</strong> volatile amines(the odor causing gas) and microscopic detection <strong>of</strong> cluecells 2 (6).Current medical therapy for vaginitis includes the use <strong>of</strong>systemic or topical antibiotic and antifungalpreparations. Vaginitis being a disorder <strong>of</strong> multifactorialetiology, a single-line therapy is <strong>of</strong>ten inadequate andrecurrence is a common complication. Though thesemedications may temporarily reduce infection, they<strong>of</strong>ten disrupt the balance <strong>of</strong> good bacteria and frequentlylead to recurrent infection. Studies shows thatvulvovaginal candiasis(VVC) affects three-quarters <strong>of</strong>women during their lifetimes and use <strong>of</strong> antibiotics is anacknowledged trigger for VVC, which adversely affectswomen's physical and emotional health (7, 8, 9).Therefore, as an alternative to these medications herbaltherapy is gaining popularity in women on account <strong>of</strong> itsreduced side effects and restoration <strong>of</strong> the normal vaginalflora (10,11,12).Ayurvedic herbs are available, which have been listed inayurvedic literatures like Dhanwanthri Nighantu,Bhavaprakash Nighandu, Ashtanga Hrdaya, Sushruta69
- Page 1:
Indian Journal of Pharmacy Practice
- Page 4 and 5:
Indian Journal of Pharmacy Practice
- Page 7 and 8:
APTIIndian J. Pharm. Pract. 1(2), J
- Page 10 and 11:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 12 and 13:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 14 and 15:
APTIijoppGenesis, Development and P
- Page 16 and 17:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 19 and 20:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 21 and 22:
Indian J. Pharm. Pract. 1(2), Jan-M
- Page 23 and 24: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 25 and 26: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 27 and 28: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 29 and 30: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 31 and 32: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 33 and 34: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 35 and 36: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 37 and 38: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 39 and 40: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 41 and 42: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 43 and 44: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 45 and 46: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 47 and 48: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 49 and 50: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 51 and 52: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 53 and 54: pivotal to the rational use of medi
- Page 55 and 56: .leadership” (Cohen, 1984). A stu
- Page 57 and 58: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 59 and 60: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 61 and 62: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 63 and 64: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 65 and 66: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 67 and 68: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 69 and 70: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 71 and 72: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 73: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 77 and 78: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 79 and 80: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 81 and 82: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 83 and 84: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 85 and 86: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 87 and 88: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 89 and 90: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 91 and 92: Indian J. Pharm. Pract. 1(2), Jan-M
- Page 93 and 94: Indian J. Pharm. Pract. 1(2), Jan-M